Glibornuride (Glutril - Roche) was developed in the late ‘sixties and has just been marketed in Britain. Like glibenclamide (Daonil; Euglucon)1 and glipizide (Minodiab; Glibenese)2 it is a ‘second generation’ sulphonylurea which lowers blood glucose when given in smaller doses than earlier sulphonylureas.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.